Monday, June 3, 2019
Acting for private equity fund Duke Street on the Irish aspects of the acquisition of DCC’s generic drug business with operations in Ireland and Britain.
The deal included British drugs business Kent Pharmaceuticals and an associated Irish manufacturer, Athlone Laboratories.
Duke Street, a London-based private equity house, is a prolific acquirer of medium-sized business across Europe across a broad range of sectors.
More information available here.